Bone anchored hearing aid (BAHA) for Conductive Hearing Loss
Study Summary
This trial is testing two types of hearing devices to see which works better.
- Conductive Hearing Loss
- Unilateral Hearing Loss
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 2 Secondary · Reporting Duration: Up to 14 weeks
Trial Safety
Safety Progress
Trial Design
6 Treatment Groups
Single-Sided Deafness Adult (Aim1) Group
1 of 6
Pediatric Unilateral Conductive Hearing Loss (Aim 3a) Group
1 of 6
Adhear followed by BAHA (Aim 3) Group
1 of 6
BAHA followed by Adhear (Aim 3) Group
1 of 6
Pediatric Bilateral Conductive Hearing Loss (Aim 3b) Group
1 of 6
Conductive Hearing Loss Adult (Aim 2) Group
1 of 6
Experimental Treatment
66 Total Participants · 6 Treatment Groups
Primary Treatment: Bone anchored hearing aid (BAHA) · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age Any Age · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are participants being accepted into this medical trial at present?
"Affirmative. The clinical trial's presence on clinicaltrials.gov demonstrates that this experiment is presently in need of participants; first posted on April 26th 2018 and last modified on August 29 2022, the study requires 90 individuals from a single site." - Anonymous Online Contributor
What is the limit to the number of individuals participating in this trial?
"Affirmative. The listing on clinicaltrials.gov reveals that this medical experiment is actively enrolling members, which was first put up for public notice on April 26th 2018 and updated most recently on the 29th of August 2022. A total of 90 individuals are needed to participate at one site." - Anonymous Online Contributor